CLINICAL_TRIALS
trial_result
· 2014-07-17
Clinical Trial Update: A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension [Phase 2]
Summary
A Phase 2 study evaluating the efficacy, safety and tolerability, and pharmacokinetics of Exenatide once-monthly suspension in people with Type 2 diabetes melli…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2014-07-17